3Badr K,Wainwright CL. Inflammation in the eardiovascular system:Here,thereand everwhere[J].Cart Opin Pharmacol,2004,(02):107-109.
4Blake GL,Rifai N,Bueing JE. Bloodpressure,C-reactiveprotein,and risk of futurecardiovascular events[J].Circulation,2003,(24):2993-2999.
5DeMota N,Reaux-Le Goazigo A,ELMessari S. Apelin,a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release[J].Proceedings of the National Academy of Sciences,2004,(28):10464.
6Zhong JC,Yu XY,Huang Y. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice[J].Cardiovascular Research,2007,(03):388-395.
7Ishida J,Hashimoto T,Hashimoto Y. Regulatory roles for APJ,a seven-transmembrane receptor related to angiotensintypel receptor in blood pressurein vivo[J].Journal of Biological Chemistry,2004,(25):26274-26279.
8Tanira MO,AI Balushi KA. Genetic variations related to hypertention:a review[J].Journal of Human Hypertension,2005,(01):7-19.
9Fejerman L,Wu X,Adeyema A. The effect of genetic variation in angiotensinogen on serum levels and blood pressure:a comparison of Nigerians and US blacks[J].JHumHypertens,2006,(11):882-887.
6Pitt B, Byington RP, Furbreg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical event [J]. Circulation,2000,102:1503 - 1510.
